abstract |
Novel hybrid cell lines produce monoclonal antibody to the light chain region of human factor XII. Three such cell lines, ATCC #HB-9703 through ATCC #HB-9704, are formed by fusing SP2/0-Ag14 myeloma cells with spleen cells from BALB/c AnSkh mice immunized with human factor XIIf. The monoclonal antibodies may be used, for example, for removing human factor XII fragments containing the factor XII light chain, from liquids, e.g. blood plasma products. |